Physician-Supervised Peptide Program
Peptide Energy & Vitality Program
Physician-supervised energy and vitality support — labs first, plan second.
A physician-supervised energy and vitality peptide program at EBO2 Therapy and Wellness. Whether any peptide is considered — and which one — is a physician decision made after consultation and baseline labs.
Quick answer
A physician-supervised energy and vitality peptide program at EBO2 Therapy and Wellness. Whether any peptide is considered — and which one — is a physician decision made after consultation and baseline labs. Physician-supervised energy and vitality support — labs first, plan second.
Program Overview
A supervised program, not an off-the-shelf product
The Peptide Energy & Vitality Program is designed for clients who want a lab-guided, physician-directed approach to daily energy, sleep quality, and overall vitality — rather than layering supplements or self-managed compounds hoping something works.
Consultation and labs come first. The supervising physician reviews your goals, medical history, current medications, sleep and stress patterns, and prior labs before considering whether a peptide fits your plan.
This program is a wellness track. It does not treat fatigue as a diagnosis, and it is not a substitute for medical evaluation of ongoing energy issues by your primary or specialty providers.
Who It's Considered For
- Adults with clear vitality and sleep-quality goals who want a physician-directed plan
- Concierge clients pairing supervised vitality peptides with NAD+, EBO3, or Red Light on the physician's guidance
- Patients who want a lab-guided cadence rather than a self-managed stack
- Individuals who understand peptides are one adjunct inside a broader wellness plan — not a treatment for fatigue or any diagnosis
Medical Oversight
Physician-directed from consultation onward
A supervising physician at EBO2 Therapy and Wellness owns each decision inside the vitality track: intake, labs, plan design, cadence, and follow-up. Nothing is transactional — the physician can adjust, pause, or discontinue any component based on how you respond and what your labs show.
Options a Physician May Consider
Peptides studied inside this category
Depending on your consultation and labs, the physician may consider one of the following categories inside a broader energy and vitality plan. These are options the physician may consider — not a menu you order from.
CJC-1295 / Ipamorelin
A combination researched in the context of growth-hormone-axis signaling and sleep-quality patterns. Consideration, cadence, and route are at physician discretion after screening.
Thymosin Alpha-1
A peptide studied for immune-signaling and vitality-adjacent applications. Whether it is appropriate — and how — is a physician decision after labs and history.
Listing here is educational only. Availability of any specific peptide, and whether it is appropriate for you, is determined by the supervising physician after consultation and labs. No outcome is promised, and no FDA approval is claimed for any wellness protocol.
How the Program Starts
Consult → labs → individualized plan
Step 1
Consultation
Private intake and physician review — goals, medical history, current medications, sleep, stress, and prior labs.
Step 2
Baseline labs
Ordered before any peptide is considered. Results anchor the physician's plan and every future adjustment.
Step 3
Individualized plan
Physician determines whether a peptide is appropriate, which category, and at what cadence. Sleep, stress, and lifestyle inputs are part of the plan.
Step 4
Follow-up
Interval reviews and labs on the physician's cadence. Adjustments, pauses, and discontinuations happen based on response.
Program length: Vitality programs are typically physician-directed cycles with follow-up labs, then reassessed. Length, cadence, and any transition are decided by the supervising physician based on how you respond.
Safety & Oversight
Non-negotiables of the program
- Baseline and interval labs are required — no peptide is added on assumption.
- The physician alone determines what is used, at what cadence, and when to pause or stop.
- Pregnancy, breastfeeding, active cancer, and certain conditions or medications may exclude or modify options.
- Any new symptom is reviewed with the clinical team before the next dose.
- The program supports — but does not replace — medical care from your primary or specialty providers.
No FDA approval is claimed for any wellness protocol. No specific energy, sleep, or vitality outcome is promised.
What Programs Cost
Discussed at consultation
Program pricing is discussed at consultation and depends on the physician's plan, labs cadence, and program length. Pricing reflects a supervised program — not a product purchase.
Related Peptide Programs
Explore other physician-supervised tracks
Weight Management Program
Physician-supervised GLP-1 and advanced options reviewed after labs.
Learn more →
Cellular Longevity Program
Mitochondrial-focused longevity peptides considered under supervision.
Learn more →
Recovery Program
Soft-tissue and post-effort recovery peptides considered under supervision.
Learn more →
FAQ
Common Questions About the Peptide Energy & Vitality Program
Who is a candidate for the Energy & Vitality Program?
How does the program start?
How long does the program run?
How is safety monitored?
What does the program cost?
Does this program treat fatigue?
Begin Your Journey
Ask about the Peptide Energy & Vitality Program
Programs start with a private consultation, labs, and a physician-directed plan — not a checkout.
Available at our clinics
Peptide Therapy in California & Florida
Explore peptide therapy at each EBO2 Therapy and Wellness location, or dig into a side-by-side comparison and the clinical guide.
Medically reviewed by Daniel Moghadam, MD.
Page updated: July 2026
This page is maintained by EBO2 Therapy and Wellness to answer common questions about Peptide Energy & Vitality Program. Content is educational and is not a substitute for consultation, screening, and provider guidance. See the full Medical Disclaimer at the end of this page.
How candidacy for Peptide Energy & Vitality Program is evaluated
- Medical history, current medications, and prior labs are reviewed at consultation.
- Baseline labs are ordered before any peptide program is started.
- Pregnancy, breastfeeding, active cancer, and certain conditions may exclude or modify options.
- Selection of any specific peptide, dose, and cadence is entirely at physician discretion.
- Peptide programs are wellness-focused and are not a substitute for medical care; results vary.
Screening, history, and provider guidance determine whether any protocol is appropriate for a given individual. Results vary.
Where this information comes from
FDA approvals for GLP-1 products such as WEGOVY are specific to a particular product, route, dose, and indication and do NOT transfer to compounded semaglutide, unapproved GLP-1 formulations, or investigational peptide stacks (e.g. BPC-157, MOTS-c, TB-500). FDA has flagged dosing errors with compounded semaglutide and safety risks with several bulk peptide substances. Programs at EBO2 remain physician-supervised.
- WEGOVY (semaglutide) — FDA prescribing label
DailyMed (U.S. National Library of Medicine)
Current FDA-approved prescribing information for WEGOVY, defining approved indication, dosing, route, and safety information. Approval is product/route/indication-specific.
- FDA alerts providers, compounders, and patients to dosing errors with compounded semaglutide
U.S. Food & Drug Administration
FDA safety alert on dosing errors associated with compounded semaglutide. Regulatory/safety context only; does not endorse compounded products.
- FDA intends to take action against non-FDA-approved GLP-1 drugs
U.S. Food & Drug Administration
FDA statement on planned enforcement against non-FDA-approved GLP-1 products. Regulatory context; not a recommendation for any specific program.
- FDA — Certain Bulk Drug Substances Used to Compound Drug Products May Present Significant Safety Risks
U.S. Food & Drug Administration
FDA safety-risk framing for bulk drug substances used in compounding — the category that covers BPC-157, MOTS-c, TB-500, and related investigational peptides. Risk/regulatory context only.
- FDA — Unapproved Drugs enforcement policy overview
U.S. Food & Drug Administration
FDA overview of how the agency treats drugs that lack FDA approval, providing regulatory context for compounded and unapproved products.
References describe general evidence, safety, or regulatory context. They do not establish an individual benefit for any specific person, and they do not validate EBO2's proprietary clinic protocols.